Which has better earnings and valuation, AVAH or DVA?

DaVita has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aveanna Healthcare $2.43B 1.20 $225.03M $1.23 10.83 DaVita $13.64B 0.84 $746.80M $12.22 14.75

Does the media prefer AVAH or DVA?

In the previous week, Aveanna Healthcare had 2 more articles in the media than DaVita. MarketBeat recorded 13 mentions for Aveanna Healthcare and 11 mentions for DaVita. DaVita's average media sentiment score of 1.48 beat Aveanna Healthcare's score of 1.07 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AVAH or HIMS?

In the previous week, Hims & Hers Health had 31 more articles in the media than Aveanna Healthcare. MarketBeat recorded 44 mentions for Hims & Hers Health and 13 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.07 beat Hims & Hers Health's score of 0.34 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 8 Very Positive mention(s) 5 Positive mention(s) 25 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation & earnings, AVAH or HNGE?

Aveanna Healthcare has higher revenue and earnings than Hinge Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aveanna Healthcare $2.43B 1.20 $225.03M $1.23 10.83 Hinge Health $587.86M 12.37 -$528.26M $1.28 70.41

Does the media prefer AVAH or HNGE?

In the previous week, Aveanna Healthcare had 9 more articles in the media than Hinge Health. MarketBeat recorded 13 mentions for Aveanna Healthcare and 4 mentions for Hinge Health. Aveanna Healthcare's average media sentiment score of 1.07 beat Hinge Health's score of 0.46 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, CHE or AVAH?

Chemed has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.60B 2.62 $265.24M $19.91 26.17 Aveanna Healthcare $2.43B 1.20 $225.03M $1.23 10.83

Does the media favor CHE or AVAH?

In the previous week, Chemed had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 14 mentions for Chemed and 13 mentions for Aveanna Healthcare. Chemed's average media sentiment score of 1.53 beat Aveanna Healthcare's score of 1.07 indicating that Chemed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 13 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Aveanna Healthcare 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aveanna Healthcare (AVAH) Competitors

$13.32 +0.13 (+0.95%)

As of 11:09 AM Eastern

Compare

AVAH vs. DVA, BTSG, HIMS, HNGE, and CHE

Should you buy Aveanna Healthcare stock or one of its competitors? Aveanna Healthcare's main competitors and comparable companies include DaVita (DVA), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), Hinge Health (HNGE), and Chemed (CHE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Aveanna Healthcare compare to DaVita?

Aveanna Healthcare (NASDAQ:AVAH) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Aveanna Healthcare has a beta of 1.97, suggesting that its stock price is 97% more volatile than the broader market. Comparatively, DaVita has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Aveanna Healthcare presently has a consensus price target of $13.50, indicating a potential upside of 1.31%. DaVita has a consensus price target of $221.75, indicating a potential upside of 23.01%. Given DaVita's higher probable upside, analysts plainly believe DaVita is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

DaVita has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.20	$225.03M	$1.23	10.83
DaVita	$13.64B	0.84	$746.80M	$12.22	14.75

In the previous week, Aveanna Healthcare had 2 more articles in the media than DaVita. MarketBeat recorded 13 mentions for Aveanna Healthcare and 11 mentions for DaVita. DaVita's average media sentiment score of 1.48 beat Aveanna Healthcare's score of 1.07 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by insiders. Comparatively, 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.56% compared to DaVita's net margin of 6.05%. Aveanna Healthcare's return on equity of 80.70% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
DaVita	6.05%	-217.63%	5.07%

Summary

Aveanna Healthcare beats DaVita on 10 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to BrightSpring Health Services?

Aveanna Healthcare (NASDAQ:AVAH) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Aveanna Healthcare currently has a consensus target price of $13.50, indicating a potential upside of 1.31%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 17.07%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

88.0% of Aveanna Healthcare shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.56% compared to BrightSpring Health Services' net margin of 2.55%. Aveanna Healthcare's return on equity of 80.70% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
BrightSpring Health Services	2.55%	16.73%	5.24%

In the previous week, Aveanna Healthcare had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Aveanna Healthcare and 12 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.43 beat Aveanna Healthcare's score of 1.07 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	11 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aveanna Healthcare has higher earnings, but lower revenue than BrightSpring Health Services. Aveanna Healthcare is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.20	$225.03M	$1.23	10.83
BrightSpring Health Services	$14.37B	0.83	$190.67M	$1.66	36.38

Aveanna Healthcare has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

Summary

Aveanna Healthcare beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hims & Hers Health?

Aveanna Healthcare (NASDAQ:AVAH) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Aveanna Healthcare has a net margin of 10.56% compared to Hims & Hers Health's net margin of -5.51%. Aveanna Healthcare's return on equity of 80.70% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Aveanna Healthcare has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.20	$225.03M	$1.23	10.83
Hims & Hers Health	$2.35B	2.77	$128.37M	-$0.63	N/A

Aveanna Healthcare has a beta of 1.97, suggesting that its stock price is 97% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, suggesting that its stock price is 142% more volatile than the broader market.

Aveanna Healthcare currently has a consensus target price of $13.50, suggesting a potential upside of 1.31%. Hims & Hers Health has a consensus target price of $32.50, suggesting a potential upside of 16.77%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

In the previous week, Hims & Hers Health had 31 more articles in the media than Aveanna Healthcare. MarketBeat recorded 44 mentions for Hims & Hers Health and 13 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.07 beat Hims & Hers Health's score of 0.34 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	8 Very Positive mention(s)	5 Positive mention(s)	25 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Aveanna Healthcare beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hinge Health?

Aveanna Healthcare (NASDAQ:AVAH) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Hinge Health has a net margin of 15.15% compared to Aveanna Healthcare's net margin of 10.56%. Aveanna Healthcare's return on equity of 80.70% beat Hinge Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Hinge Health	15.15%	51.60%	14.16%

Aveanna Healthcare has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Hinge Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.20	$225.03M	$1.23	10.83
Hinge Health	$587.86M	12.37	-$528.26M	$1.28	70.41

In the previous week, Aveanna Healthcare had 9 more articles in the media than Hinge Health. MarketBeat recorded 13 mentions for Aveanna Healthcare and 4 mentions for Hinge Health. Aveanna Healthcare's average media sentiment score of 1.07 beat Hinge Health's score of 0.46 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Aveanna Healthcare presently has a consensus price target of $13.50, indicating a potential upside of 1.31%. Hinge Health has a consensus price target of $100.57, indicating a potential upside of 11.58%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts plainly believe Hinge Health is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Hinge Health beats Aveanna Healthcare on 9 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Chemed?

Chemed (NYSE:CHE) and Aveanna Healthcare (NASDAQ:AVAH) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.97, indicating that its stock price is 97% more volatile than the broader market.

Chemed currently has a consensus price target of $530.75, suggesting a potential upside of 1.85%. Aveanna Healthcare has a consensus price target of $13.50, suggesting a potential upside of 1.31%. Given Chemed's higher probable upside, equities analysts plainly believe Chemed is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Chemed has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.60B	2.62	$265.24M	$19.91	26.17
Aveanna Healthcare	$2.43B	1.20	$225.03M	$1.23	10.83

95.8% of Chemed shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Chemed has a net margin of 10.60% compared to Aveanna Healthcare's net margin of 10.56%. Aveanna Healthcare's return on equity of 80.70% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Aveanna Healthcare	10.56%	80.70%	7.42%

In the previous week, Chemed had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 14 mentions for Chemed and 13 mentions for Aveanna Healthcare. Chemed's average media sentiment score of 1.53 beat Aveanna Healthcare's score of 1.07 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	13 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Aveanna Healthcare	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Chemed beats Aveanna Healthcare on 11 of the 17 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVAH vs. The Competition

Export

Metric	Aveanna Healthcare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.91B	$10.00B	$7.23B	$12.80B
Dividend Yield	N/A	2.57%	2.53%	8.56%
P/E Ratio	10.84	34.54	273.73	25.30
Price / Sales	1.20	5.61	680.57	123.92
Price / Cash	19.52	121.27	76.98	52.08
Price / Book	10.09	3.96	12.96	6.12
Net Income	$225.03M	$310.54M	$3.47B	$349.11M
7 Day Performance	-3.58%	-0.60%	-0.35%	-1.66%
1 Month Performance	38.66%	-0.05%	6.47%	2.27%
1 Year Performance	59.77%	15.01%	24.94%	15.58%

Aveanna Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVAH Aveanna Healthcare	3.8405 of 5 stars	$13.33 +0.9%	$13.50 +1.3%	+60.2%	$2.91B	$2.43B	10.84	35,500	Positive News
DVA DaVita	4.9527 of 5 stars	$177.84 +0.8%	$221.75 +24.7%	+31.1%	$11.35B	$13.64B	14.55	78,000	Positive News
BTSG BrightSpring Health Services	4.7832 of 5 stars	$57.23 -3.8%	$70.71 +23.5%	+152.3%	$11.32B	$12.91B	34.48	23,500	Positive News
HIMS Hims & Hers Health	2.4055 of 5 stars	$31.73 +2.1%	$32.50 +2.4%	-31.2%	$7.40B	$2.35B	N/A	2,442	Trending News Gap Down
HNGE Hinge Health	3.4235 of 5 stars	$89.40 -0.6%	$100.57 +12.5%	+66.2%	$7.21B	$587.86M	69.84	1,437

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Competitors

AVAH vs. DVA, BTSG, HIMS, HNGE, and CHE

How does Aveanna Healthcare compare to DaVita?

Summary

How does Aveanna Healthcare compare to BrightSpring Health Services?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Summary

How does Aveanna Healthcare compare to Hinge Health?

Summary

How does Aveanna Healthcare compare to Chemed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Competitors

AVAH vs. DVA, BTSG, HIMS, HNGE, and CHE

How does Aveanna Healthcare compare to DaVita?

Which has more risk and volatility, AVAH or DVA?

Do analysts rate AVAH or DVA?

Which has better earnings and valuation, AVAH or DVA?

Does the media prefer AVAH or DVA?

Do insiders and institutionals believe in AVAH or DVA?

Is AVAH or DVA more profitable?

Summary

How does Aveanna Healthcare compare to BrightSpring Health Services?

Do analysts recommend AVAH or BTSG?

Do insiders and institutionals hold more shares of AVAH or BTSG?

Is AVAH or BTSG more profitable?

Does the media prefer AVAH or BTSG?

Which has higher valuation and earnings, AVAH or BTSG?

Which has more volatility and risk, AVAH or BTSG?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Is AVAH or HIMS more profitable?

Do insiders & institutionals hold more shares of AVAH or HIMS?

Which has stronger valuation & earnings, AVAH or HIMS?

Which has more volatility & risk, AVAH or HIMS?

Do analysts prefer AVAH or HIMS?

Does the media prefer AVAH or HIMS?

Summary

How does Aveanna Healthcare compare to Hinge Health?

Is AVAH or HNGE more profitable?

Which has more volatility and risk, AVAH or HNGE?

Which has higher valuation & earnings, AVAH or HNGE?

Does the media prefer AVAH or HNGE?

Do insiders and institutionals believe in AVAH or HNGE?

Do analysts recommend AVAH or HNGE?

Summary

How does Aveanna Healthcare compare to Chemed?

Which has more risk & volatility, CHE or AVAH?

Do analysts rate CHE or AVAH?

Which has higher valuation & earnings, CHE or AVAH?

Do insiders and institutionals hold more shares of CHE or AVAH?

Is CHE or AVAH more profitable?

Does the media favor CHE or AVAH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools